Ratings AXA

Equities

CS

FR0000120628

Market Closed - Euronext Paris Other stock markets 11:36:54 2023-12-01 am EST			Pre-market 02:28:36 am
28.90 ^EUR	+1.05%		28.85	-0.16%

Nov. 30	UK health insurance rates to soar on surging claims-industry experts	RE
Nov. 29	AXA : Deutsche Bank raises its price target	CF

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
According to Refinitiv, the company's ESG score for its industry is good.

Strengths

The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
With regards to fundamentals, the enterprise value to sales ratio is at 0.95 for the current period. Therefore, the company is undervalued.
The company is one of the best yield companies with high dividend expectations.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector : Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
AXA	+10.90%	68 575 M $	B-
AFLAC INCORPORATED	+14.83%	48 276 M $	B
METLIFE, INC.	-11.90%	47 195 M $	B+
MANULIFE FINANCIAL CORPORATION	+10.27%	35 749 M $	B+
PRUDENTIAL FINANCIAL, INC.	-1.73%	35 315 M $	B+
GENERALI	+14.08%	31 069 M $	B
GREAT-WEST LIFECO INC.	+39.62%	30 186 M $	B-
PRUDENTIAL PLC	-22.94%	30 183 M $	A-
SUN LIFE FINANCIAL INC.	+9.51%	29 789 M $	B
CATHAY FINANCIAL HOLDING CO., LTD.	+15.13%	21 504 M $	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes